CRVS Price / Book | Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. (CRVS) Price / Book

2026-08-27: Price/Book Ratio 5.5.
2026-06-30: Price/Book Ratio 5.58.
2026-03-31: Price/Book Ratio 5.11.
2025-12-31: Price/Book Ratio 9.4.

Historical market capitalization divided by filed shareholder equity.

Available history: 2016-03-31 to 2026-08-27
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-08-27	5.5
2026-06-30	5.58
2026-03-31	5.11
2025-12-31	9.4
2025-09-30	7.67
2025-06-30	3.72
2025-03-31	4.39
2024-12-31	11.15
2024-09-30	26.63
2024-06-30	2.22
2024-03-31	2.62
2023-12-31	2.23
2023-09-30	1.62
2023-06-30	2.26
2023-03-31	0.87
2022-12-31	0.71
2022-09-30	0.59
2022-06-30	0.57
2022-03-31	0.85
2021-12-31	1.15
2021-09-30	2.14
2021-06-30	1.17
2021-03-31	1.25
2020-12-31	1.4
2020-09-30	2.66
2020-06-30	1.5
2020-03-31	0.98
2019-12-31	2.14
2019-09-30	1.1
2019-06-30	1.22
2019-03-31	1.17
2018-12-31	0.98
2018-09-30	2.11
2018-06-30	2.52
2018-03-31	2.45
2017-12-31	2.57
2017-09-30	3.56
2017-06-30	2.42
2017-03-31	3.68
2016-12-31	2.25
2016-09-30	2.41
2016-06-30	1.96
2016-03-31	1.94

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Janux Therapeutics, Inc. (JANX)	United States	$1.019B	-9.15
Pacira BioSciences, Inc. (PCRX)	United States	$1.020B	69.03
Kura Oncology, Inc. (KURA)	United States	$0.967B	-3.29
Arbutus Biopharma Corp (ABUS)		$0.965B	6.19
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.031B	-5.43
Savara Inc (SVRA)	United States	$1.044B	-9.10
Jade Biosciences, Inc. (JBIO)	United States	$0.936B	-9.21
MANNKIND CORP (MNKD)	United States	$1.058B	-30.41
Alto Neuroscience, Inc. (ANRO)	United States	$1.065B	-11.02
Apnimed, Inc. (APMD)	United States	$0.899B